Mavoglurant Improves Visual Attention in Fragile X Syndrome

WEDNESDAY, Jan. 23, 2019 -- For patients with fragile X syndrome (FXS), mavoglurant treatment improves visual attention and pupil reactivity, according to a study published online Jan. 17 in PLOS ONE. David Hessl, Ph.D., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news